Spinal cord injury

Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in The Villages, Florida

Retrieved on: 
Monday, September 26, 2022
EHC, Lists of diseases, Nursing, Medicare, Twitter, Fortune, NYSE, Encompass Health, Spinal cord injury, Company, Stroke, Environment, Disease, Patient, Physician, Garden, Instagram, Quality of life, Injury, Encompass, Amputation, Newsroom, Pharmacy, Rehabilitation, SEC, Brain, Hospital, Village, Health insurance, Facebook, Health care

BIRMINGHAM, Ala., Sept. 26, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it plans to build Encompass Health Rehabilitation Hospital of Wildwood, a freestanding, 50-bed inpatient rehabilitation hospital in The Villages, Florida.

Key Points: 
  • BIRMINGHAM, Ala., Sept. 26, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it plans to build Encompass Health Rehabilitation Hospital of Wildwood, a freestanding, 50-bed inpatient rehabilitation hospital in The Villages, Florida.
  • In addition to 24hour nursing care, this hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life.
  • Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States.
  • In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein.

World EMS (Emergency Medical Services) Vehicles Market Report 2022-2030: Market to Remain Fragmented with Extreme Level of Competition - Growth Trends, Key Players, Competitive Strategies & Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022
Health, Hospitals, Emergency medical services, World Bank, Lists of diseases, Cardiac arrest, Element, Department, CVD, Prevalence, United Nations, Population, Life, Immunity, Industry, Stroke, World, Coronary artery disease, Person, Government, Patient, Investment, Consulate, Cancer, Trauma, British Heart Foundation, United Kingdom, Injury, Degenerative disease, Spinal cord injury, Medical tourism, EMS, Death, United Nations Department of Economic and Social Affairs, Ministry of Social Affairs, Health care, Hospital, Heart failure, Conditional sentence, First Nations in Ontario, CAGR, Renewable energy, Health insurance, Pharmaceutical industry, Healthcare

The "EMS (Emergency Medical Services) Vehicles Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "EMS (Emergency Medical Services) Vehicles Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global EMS vehicles market is experiencing revenue growth as a result of the increasing reliance on emergency medical services to assist critical treatment.
  • Another change that is thought to present a sizable opportunity for the global market for emergency medical services vehicles is the use of drones to transport medical supplies.
  • The market for emergency medical services (EMS) vehicles is extremely fragmented, with leading manufacturers present everywhere.

WORLD RECORD HOLDER, IAN MACKAY, SETS OUT ON 475-MILE SOLO TREK VIA WHEELCHAIR FROM D.C. TO OHIO ON GREAT AMERICAN RAIL-TRAIL®

Retrieved on: 
Wednesday, September 21, 2022
Ride, Disability, Medicare, Twitter, Spinal cord injury, National Mall, Legislation, Nature, Great American Rail-Trail, Program, Maintenance, Wheelchair, Travel, RTC, National Park Service, Walking, Instagram, Protected area, Veteran, Transport, SCI/D, Medicine, Congress, Awareness, Multimedia, Guinness, Mall, View, Ridesharing company, Road, Taxicab, D.C, American, Washington State, Policy, Facebook, United Spinal Association

WASHINGTON, Sept. 21, 2022 /PRNewswire/ -- Ian's Ride, Rails-to-Trails Conservancy (RTC) and United Spinal Association (USA) gathered with members and supporters today on the National Mall to celebrate the launch of Ian Mackay's journey on the Great American Rail-Trail® from Washington, D.C., to Columbus, Ohio. Mackay, founder of Ian's Ride and an accessibility advocate, will travel 475-miles by power wheelchair on the easternmost portion of the Great American to raise awareness of the importance of and the need for more access to the outdoors for people with mobility impairments and other disabilities.

Key Points: 
  • "My philosophy is: community is the answer, we are stronger together and nature is the best medicine."
  • "We are thrilled to cheer on Ian as he sets off along the Great American Rail-Trail," said Kevin Belanger, RTC's project manager for the Great American Rail-Trail.
  • Mackay's ride on the Great American Rail-Trail comes as several priorities are being pursued in Congress.
  • Mackay recently broke a Guinness World Record for the farthest distancemore than 184 milesin 24 hours on a mouth-controlled power wheelchair.

Dallas-based Trial Lawyer Michael Lyons Again Earns Place Among Top 100 Texas Attorneys

Retrieved on: 
Wednesday, September 21, 2022
Fire, Rising Star, Personal injury, Brain, Spinal cord injury, Thomson Reuters, Accident, Lawyer, LLP, Simmons, International Best Dressed Hall of Fame List, Insurance, Frank Andrews (Texas lawyer)

DALLAS, Sept. 21, 2022 /PRNewswire/ -- Co-founder of the trial law firm Lyons & Simmons Michael Lyons has been recognized for a second consecutive year among the Top 100 attorneys in the state by the Texas Super Lawyers. Additionally, for the fourth consecutive year, Lyons was honored among the Top 100 Super Lawyers for Dallas-Fort Worth.

Key Points: 
  • DALLAS, Sept. 21, 2022 /PRNewswire/ -- Co-founder of the trial law firm Lyons & Simmons Michael Lyons has been recognized for a second consecutive year among the Top 100 attorneys in the state by the Texas Super Lawyers.
  • Additionally, for the fourth consecutive year, Lyons was honored among the Top 100 Super Lawyers for Dallas-Fort Worth.
  • The selections further solidify Lyons & Simmons' position among the state's preeminent personal injury firms.
  • The firm was recently selected as Dallas' top-rated personal injury law firm by readers of Texas Lawyer, securing the firm's place in the magazine's "Best of" Hall of Fame.

ONWARD to Release Half-Year 2022 Financial Results and Host Webcast on September 27, 2022

Retrieved on: 
Wednesday, September 21, 2022
Software, Biotechnology, Finance, Hardware, Health, Medical Devices, Professional Services, Technology, Health, Movement, High Tech Campus Eindhoven, U.S. FDA, Spinal cord, Spinal cord injury, Nature, Company, Forward-looking statement, Technology, Quality of life, Science, ARC, Webcast, Euronext, Medical device, Broadcasting, Health insurance, Risk management

Management will host a webcast to discuss operational and financial highlights, as well as provide a business update on September 27, 2022, at 16:00 CEST/10:00 EDT.

Key Points: 
  • Management will host a webcast to discuss operational and financial highlights, as well as provide a business update on September 27, 2022, at 16:00 CEST/10:00 EDT.
  • Participants may also join by phone:
    A recording of the webcast will be available on the Companys website following the live event.
  • ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries.
  • You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

ONWARD Reports Positive Topline Results from a Pivotal Study to Restore Arm and Hand Function in People With Spinal Cord Injury

Retrieved on: 
Tuesday, September 13, 2022
Health, Medical Devices, Surgery, Physical Therapy, Other Science, Research, Science, Safety, Movement, Christopher and Dana Reeve Foundation, Research, Sensation, Nature, Electricity, Infection, Emory University School of Medicine, Paralysis, PT, Technology, Computer engineering, ARC, Shepherd Center, Time, U.S. FDA, Spinal cord injury, Company, High Tech Campus Eindhoven, Science, University of Washington Department of Bioengineering, Assessment, SCI, Spinal cord, FDA, Review, Forward-looking statement, Hand, Incontinence, Prehensility, Health, Doctor of Philosophy, Department, Loss of Sensation, Quality of life, Physical medicine and rehabilitation, Ascending limb of loop of Henle, Grade, University, Euronext, Trapping, Pharmaceutical industry, Medical device, Medicine

ARC-EX Therapy is a proprietary non-invasive spinal cord stimulation technology designed to restore movement and other functions in people with movement disabilities.

Key Points: 
  • ARC-EX Therapy is a proprietary non-invasive spinal cord stimulation technology designed to restore movement and other functions in people with movement disabilities.
  • Our vision is to empower people with spinal cord injury to enjoy life in every way that matters to them.
  • Todays excellent results from the Up-LIFT study will help us transform that vision into reality, said Dave Marver, ONWARD CEO.
  • We are hopeful we can begin to positively impact the lives of people with spinal cord injury sometime during the second half of 2023.

German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals

Retrieved on: 
Monday, September 12, 2022
Paraplegia, Risk, Adoption, Time, Spinal cord, Spinal cord injury, Form 10-K, Review, Hearing, Stroke, U.S. Securities and Exchange Commission, Patient, Phrase, CEO, United Kingdom, Quality of life, Uncertainty, Nasdaq, Private Securities Litigation Reform Act, Insurance, Security (finance), GLOBE, SEC, Annual report, Classification, SHI, Robotics, Medical device, Health insurance, ReWalk

The courts decision will establish a new national policy for exoskeleton medical aids and will apply nationally to all Germans covered by Statutory Health Insurance (SHI).

Key Points: 
  • The courts decision will establish a new national policy for exoskeleton medical aids and will apply nationally to all Germans covered by Statutory Health Insurance (SHI).
  • Establishing a legal classification for exoskeletons will provide guidance for both patients and insurance companies, setting a reliable legal basis for the application process for the provision of exoskeletons.
  • The German healthcare system has led the way in its adoption of exoskeletons for spinal cord injured individuals.
  • ReWalk Robotics Ltd.develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.

InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference

Retrieved on: 
Friday, September 9, 2022
Health, Other Health, Other Science, Clinical Trials, Research, Science, Biotechnology, Massachusetts General Hospital, Massachusetts Institute of Technology, Research, Therapy, Boston, Invivo Wines, Spinal cord injury, PAETEC Holding Corp., Hospital, Conference, Pharmaceutical industry, Technology

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright 24th Annual Global Investment Conference, which runs from September 12 14, 2022.

Key Points: 
  • InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright 24th Annual Global Investment Conference, which runs from September 12 14, 2022.
  • Dr. Toselli and company management will also be available to participate in virtual one-on-one meetings with registered investors attending the conference.
  • A webcast of Dr. Tosellis presentation will be available on the Investor Relations - Events section of the company website at https://investors.invivotherapeutics.com/events , beginning September 12, 2022 at 7:00 am ET.
  • InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.

Bionik Laboratories Acquires Florida Rehabilitation Center; First in Strategic National Rollout

Retrieved on: 
Thursday, September 8, 2022
Robotics, Health, Technology, Neurology, Hospitals, Other Technology, Physical Therapy, Government, Brain, Solution, Survivor, Robotics, Sale, Rehabilitation, LinkedIn, SEC, Spinal cord injury, Center, Ascending limb of loop of Henle, Stroke, Company, Neuro, Twitter, Projection, COVID-19, Terminology, Public expenditure, Acquisition, Forward-looking statement, Patient, Income, Risk management, Facebook

This accretive transaction represents an exciting step in Bioniks evolution and comes with numerous strategic advantages, said Richard Russo, Jr., Bioniks Interim CEO and Chief Financial Officer.

Key Points: 
  • This accretive transaction represents an exciting step in Bioniks evolution and comes with numerous strategic advantages, said Richard Russo, Jr., Bioniks Interim CEO and Chief Financial Officer.
  • Mr. Russo continued, We are pleased to secure this financing from an existing investor, demonstrating strong belief in our national rollout strategy.
  • Bionik Laboratories is a robotics company focused on providing neurological functional recovery solutions to stroke survivors and others with neurological and mobility challenges.
  • Bionik has recently launched its Neuro-Recovery Centers of Excellence strategy, to showcase Bioniks technology and solutions in an existing framework of revenue generating and profitable rehabilitation centers.

ONWARD Announces Participation at Upcoming Investor Events in September

Retrieved on: 
Wednesday, September 7, 2022
Professional Services, Health, Surgery, Finance, Managed Care, Biotechnology, Technology, ARC, Hyperreflexia, Science, High Tech Campus Eindhoven, Spinal cord injury, Quality of life, CFO, Movement, Company, FDA, Spinal cord, Health, Nature, Risk management

ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries.

Key Points: 
  • ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries.
  • ONWARD has received three Breakthrough Device Designations from the U.S. FDA, encompassing both ARCIM and ARCEX.
  • These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein.
  • You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.